📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Vernalis

1.1 - Company Overview

Vernalis Logo

Vernalis

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of fragment- and structure-based drug discovery, research collaborations with pharmaceutical, biotechnology and academic partners, and KNIME open-source software nodes for data access, cheminformatics and structural informatics; develops Chk1 and Hsp90 inhibitors. A revenue-generating development-stage pharmaceutical company advancing promising product candidates along a commercially focused path to market.

Products and services

  • Structure-Based Drug Discovery: Architects novel drug-like molecules via a structure-guided approach that integrates structural, thermodynamic, and kinetic datasets to optimize binding affinities across diverse biological targets
  • Fragment-Based Drug Discovery: Engineers potent ligands and drugs using low-molecular-weight fragments to identify key interactions at target binding sites and guide subsequent molecule development
  • Research Collaborations: Delivers cross-institutional drug discovery research with pharmaceutical, biotechnology companies, and academic institutions, producing pipeline candidates from collaborative programs aligned to a commercially-focused path to market

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Vernalis

Caraway Therapeutics Logo

Caraway Therapeutics

HQ: United States Website
  • Description: Provider of precision small-molecule therapeutics for CNS and rare diseases, developing medicines that enhance cellular clearance by activating the lysosome to remove toxic materials and defective cellular components. Leverages modulation of mitophagy and autophagy to use natural clearance pathways, preventing cell damage and treating neurodegenerative disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Caraway Therapeutics company profile →
Arcion Therapeutics Logo

Arcion Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology research and development focused on developing treatments for chronic pain.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arcion Therapeutics company profile →
Vycor Medical Logo

Vycor Medical

HQ: United States Website
  • Description: Provider of medical devices for neurological brain and spinal surgical procedures.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vycor Medical company profile →
Balt Logo

Balt

HQ: France Website
  • Description: Provider of interventional neuroradiology (INR) devices for treating strokes, aneurysms, and arteriovenous malformations. BALT designs, manufactures, and distributes essential devices such as catheters, stents, and coils, working with neurovascular surgeons to address complex, life-threatening conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Balt company profile →
Wallaby Medical Logo

Wallaby Medical

HQ: United States Website
  • Description: Provider of the Avenir coil system and medical devices for stroke treatment, operating as a manufacturing company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Wallaby Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Vernalis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Vernalis

2.2 - Growth funds investing in similar companies to Vernalis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Vernalis

4.2 - Public trading comparable groups for Vernalis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Vernalis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Vernalis

What does Vernalis do?

Vernalis is a provider of fragment- and structure-based drug discovery, research collaborations with pharmaceutical, biotechnology and academic partners, and KNIME open-source software nodes for data access, cheminformatics and structural informatics; develops Chk1 and Hsp90 inhibitors. A revenue-generating development-stage pharmaceutical company advancing promising product candidates along a commercially focused path to market.

Who are Vernalis's competitors?

Vernalis's competitors and similar companies include Caraway Therapeutics, Arcion Therapeutics, Vycor Medical, Balt, and Wallaby Medical.

Where is Vernalis headquartered?

Vernalis is headquartered in United Kingdom.

How many employees does Vernalis have?

Vernalis has 1,000 employees 🔒.

When was Vernalis founded?

Vernalis was founded in 2010 🔒.

What sector and industry vertical is Vernalis in?

Vernalis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Vernalis

Who are the top strategic acquirers in Vernalis's sector and industry

Top strategic M&A buyers and acquirers in Vernalis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Vernalis?

Top strategic M&A buyers groups and sectors for Vernalis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Vernalis's sector and industry vertical

Which are the top PE firms investing in Vernalis's sector and industry vertical?

Top PE firms investing in Vernalis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Vernalis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Vernalis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Vernalis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Vernalis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Vernalis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Vernalis?

The key public trading comparables and valuation benchmarks for Vernalis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Vernalis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Vernalis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Vernalis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Vernalis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Vernalis's' sector and industry vertical?

Access recent funding rounds and capital raises in Vernalis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Vernalis